Randomized trial estimates population direct effect from non-target group counts, suggesting improved efficiency for interventions.
In cluster trials of interventions which target a subset of the at-risk population, contemporaneous event counts in a non-target group can be used in estimating the population direct effect if indirect effects are unlikely, but the application of this approach has been limited. We describe the rationale for using the contemporaneous counts approach in the WHO’s Malaria Vaccine Programme Evaluation and how it was applied, and in a re-analysis of a human rotavirus vaccine trial, we demonstrate its application and compare results to conventional methods using event rates per person-time. Indirect effects were considered unlikely because the target group represents a very small proportion of the at-risk population. The population direct effect of intervention introduction in the target group is estimated by comparing between arms the ratio of event counts in the target group to the non-target group. Expanding surveillance into a non-target group may often be possible without significant additional costs. Confounding due to chance imbalance is reduced implicitly insofar that there is better balance in the relative difference between the target and non-target groups than in the variable itself within the target group alone. The approach can improve efficiency when target-group event counts are more strongly correlated with non-target-group counts than they are with target-group person-time, which is more likely as heterogeneity increases. The contemporaneous counts approach can increase the efficiency and internal validity of cluster trials and reduce their operational complexity since person-time denominators are not used.
No takes yet. Share an insight, caveat, or question.
Moore et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: